GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » Gross Margin %

Tianda Pharmaceuticals (HKSE:00455) Gross Margin % : 43.93% (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Tianda Pharmaceuticals's Gross Profit for the six months ended in Dec. 2023 was HK$100.4 Mil. Tianda Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was HK$228.6 Mil. Therefore, Tianda Pharmaceuticals's Gross Margin % for the quarter that ended in Dec. 2023 was 43.93%.

Warning Sign:

Tianda Pharmaceuticals Ltd gross margin has been in long-term decline. The average rate of decline per year is -11.1%.


The historical rank and industry rank for Tianda Pharmaceuticals's Gross Margin % or its related term are showing as below:

HKSE:00455' s Gross Margin % Range Over the Past 10 Years
Min: 47.3   Med: 59.41   Max: 80.47
Current: 48.02


During the past 13 years, the highest Gross Margin % of Tianda Pharmaceuticals was 80.47%. The lowest was 47.30%. And the median was 59.41%.

HKSE:00455's Gross Margin % is ranked better than
52.74% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.48 vs HKSE:00455: 48.02

Tianda Pharmaceuticals had a gross margin of 43.93% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Tianda Pharmaceuticals was -11.10% per year.


Tianda Pharmaceuticals Gross Margin % Historical Data

The historical data trend for Tianda Pharmaceuticals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals Gross Margin % Chart

Tianda Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.47 73.46 54.60 47.30 48.02

Tianda Pharmaceuticals Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Jun23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.89 47.66 48.90 51.11 43.93

Competitive Comparison of Tianda Pharmaceuticals's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tianda Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianda Pharmaceuticals's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianda Pharmaceuticals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Tianda Pharmaceuticals's Gross Margin % falls into.



Tianda Pharmaceuticals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Tianda Pharmaceuticals's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=255.5 / 532.089
=(Revenue - Cost of Goods Sold) / Revenue
=(532.089 - 276.557) / 532.089
=48.02 %

Tianda Pharmaceuticals's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=100.4 / 228.605
=(Revenue - Cost of Goods Sold) / Revenue
=(228.605 - 128.17) / 228.605
=43.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Tianda Pharmaceuticals  (HKSE:00455) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Tianda Pharmaceuticals had a gross margin of 43.93% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Tianda Pharmaceuticals Gross Margin % Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianda Pharmaceuticals (HKSE:00455) Business Description

Traded in Other Exchanges
N/A
Address
CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG
Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.
Executives
Tianda Group Limited 2101 Beneficial owner
Fang Wen Quan 2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines